DONALD LAIRD: Open Payments
NPI 1528291986 · EAST LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,329 in 185 payments from 23 companies in 2025. Trend: 2023 $2,301 · 2024 $3,543 · 2025 $3,329
Food & beverage: $3,319Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $663 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 22 | $512 |
| Janssen Biotech, Inc. | 15 | $279 |
| Lilly USA, LLC | 13 | $273 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $250 |
| Celltrion USA Inc. | 19 | $206 |
| PFIZER INC. | 9 | $180 |
| Regeneron Healthcare Solutions, Inc. | 7 | $162 |
| Gilead Sciences, Inc. | 7 | $152 |
| Ipsen Biopharmaceuticals, Inc | 6 | $103 |
Products named: XIFAXAN, RINVOQ, TREMFYA, OMVOH, VEGZELMA, ENTYVIO, DUPIXENT, LINZESS.
Industry payments across MI — which companies pay providers there.
